Comparative therapeutic effects of velaglucerase alfa and imiglucerase in a Gaucher disease mouse model.

Por You-Hai Xu, Ying Sun, Sonya Barnes, Gregory A Grabowski
Publicado em 2010-05-01

Systemic enzyme delivery by blood-brain barrier-penetrating SapC-DOPS nanovesicles for treatment of neuronopathic Gaucher disease

Por Ying Sun, Benjamin Liou, Zhengtao Chu, Venette Fannin, Rachel Blackwood, Yanyan Peng, Gregory A. Grabowski, Harold W. Davis, Xiaoyang Qi
Publicado em 2020-05-01